Statement from FDA Commissioner Scott Gottlieb, M.D., and Director of FDA ’s Center for Biologics Evaluation and Research Peter Marks, M.D., Ph.D., on efforts to promote and foster blood pathogen reduction technologies

FDA statement on efforts to promote and foster blood pathogen reduction technologies

Source: Food and Drug Administration - March 26, 2019 Category: American Health Source Type: news